| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $12,225,110 ) |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI143934 | The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells | 000 | 5 | NIH | 1/17/2024 | $619,602 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA279795 | Proteome-wide base editor screens to assess phosphorylation site functionality in immunosenescence | 000 | 1 | NIH | 4/9/2024 | $573,738 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R61AI183471 | HIV mRNA vaccine strategies for efficient priming, diversity and durability of immune responses | 000 | 1 | NIH | 4/1/2024 | $892,826 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI180152 | Dysregulation of TET dioxygenase function as a source of aberrant transposable element expression during human aging | 000 | 1 | NIH | 3/20/2024 | $658,800 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI180853 | Illuminating Lujo virus glycoprotein structure, receptor engagement and neutralizing antibody epitopes | 000 | 1 | NIH | 11/24/2023 | $247,050 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI180456 | What is the human antibody response to measles virus vaccination? | 000 | 1 | NIH | 12/1/2023 | $247,050 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI173927 | Experimental identification of functional GWAS variants linked to COVID-19 severity in immune cells | 000 | 2 | NIH | 4/17/2024 | $274,500 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01DK135683 | Genetic studies linking LSP1 function in T cells to Inflammatory Bowel Disease | 000 | 2 | NIH | 1/12/2024 | $362,340 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI170010 | Dynamic analysis of beta cell attacks in response to virus infection in Human pancreatic slices | 000 | 2 | NIH | 2/9/2024 | $205,875 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI167892 | HIPC Data Coordinating Center | 001 | 3 | NIH | 3/20/2024 | $445,252 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI167892 | HIPC Data Coordinating Center | 000 | 3 | NIH | 3/18/2024 | $3,018,229 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI153500 | Maternal Antibody-Mediated Enhancement of Dengue Pathogenesis | 000 | 4 | NIH | 2/22/2024 | $511,547 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R37AI125068 | Maximizing germinal centers and somatic hypermutation to HIV Env immunogens | 000 | 9 | NIH | 1/9/2024 | $793,821 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI150753 | Developing computational models to predict the immune response to B. pertussis booster vaccination | 000 | 5 | NIH | 2/14/2024 | $1,215,114 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI109842 | NFAT, bZIP proteins, and transcriptional programs in lymphocytes | 000 | 36 | NIH | 2/27/2024 | $758,119 |
| | 2024 | 2024 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142742 | Human immune memory to COVID-19, vaccines, and respiratory pathogens | 001 | 6 | NIH | 3/15/2024 | $2,595,434 |
| | 2024 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI167892 | HIPC Data Coordinating Center | 002 | 2 | NIH | 4/1/2024 | $25,547 |
| | 2024 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA233862 | A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy | 000 | 5 | NIH | 4/11/2024 | $0 |
| | 2024 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI118626 | Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment | 002 | 9 | NIH | 4/3/2024 | $0 |
| | 2024 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI092453 | Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes | 000 | 11 | NIH | 3/15/2024 | $0 |
| | 2024 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R37CA276779 | Evaluation of T follicular regulatory cells as novel cellular targets of cancer immunotherapy | 000 | 1 | NIH | 2/26/2024 | -$316,163 |
| | 2024 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142742 | Human immune memory to COVID-19, vaccines, and respiratory pathogens | 000 | 5 | NIH | 1/26/2024 | $0 |
| | 2024 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AR072640 | TWEAK and Skin Inflammation | 000 | 5 | NIH | 4/4/2024 | $0 |
| | 2024 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI137230 | Host nutrients permit immune evasion of NKT cell anti-bacterial responses | 000 | 5 | NIH | 11/14/2023 | $0 |
| | 2024 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI134971 | Integrated Functional Histopathology of the Diabetic Human Pancreas | 000 | 5 | NIH | 10/23/2023 | $0 |
| | 2024 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI135731 | LJI Epitope Validation Center: Characterization of epitope-specific T cells responding to food, fungal and inner city allergens | 000 | 5 | NIH | 11/16/2023 | -$54,969 |
| | 2024 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | P01HL136275 | Immune Cell Interactions in Atherosclerosis | 002 | 6 | NIH | 12/12/2023 | -$841,687 |
| | 2024 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | P01HL136275 | Immune Cell Interactions in Atherosclerosis | 001 | 6 | NIH | 12/11/2023 | $551,946 |
| | 2024 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R35CA210043 | TET enzymes as guardians of genome stability | 000 | 7 | NIH | 3/19/2024 | $0 |
| | 2024 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI118626 | Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment | 001 | 8 | NIH | 11/21/2023 | $87,183 |
| | 2024 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | S10OD030417 | Automated Multiscale Super-resolution Confocal Microscope | 000 | 1 | NIH | 4/3/2024 | $0 |
| | 2024 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI146042 | Histamine-Releasing Factor Oligomers in Food Allergy | 000 | 4 | NIH | 10/27/2023 | $0 |
| | 2024 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI128589 | Epigenetic control of Foxp3 expression in induced T regulatory cells | 000 | 5 | NIH | 2/1/2024 | $0 |
| | 2024 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | P01HL136275 | Immune Cell Interactions in Atherosclerosis | 000 | 5 | NIH | 12/11/2023 | -$551,946 |
| | 2024 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI121426 | Epigenome-wide association study of childhood asthma | 000 | 5 | NIH | 10/24/2023 | -$2,352 |
| | 2024 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI118626 | Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment | 000 | 7 | NIH | 11/21/2023 | -$87,183 |
| | 2024 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142790 | Consortium for Immunotherapeutics against Emerging Viral Threats | 001 | 3 | NIH | 1/24/2024 | $0 |
| | 2024 | 2020 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | P01HL136275 | Immune Cell Interactions in Atherosclerosis | 004 | 4 | NIH | 12/13/2023 | -$4,563 |
| | 2024 | 2020 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01HL114093 | Epigenetics of severe asthma | 000 | 9 | NIH | 12/18/2023 | $0 |
| | 2024 | 2020 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142790 | Consortium for Immunotherapeutics against Emerging Viral Threats | 000 | 2 | NIH | 1/24/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $32,752,819 ) (Continued on the next page) |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI141995 | Identifying mechanisms and correlates of long-lasting vaccine-induced immunity to whooping cough | 003 | 5 | NIH | 11/2/2022 | $823,202 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | T32AI125179 | Training in Immunological Mechanisms | 001 | 7 | NIH | 6/22/2023 | $257,278 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R24AI108564 | Research Resources: Epigenomic and Transcriptomic Profile of Human Immune Cells | 000 | 9 | NIH | 7/26/2023 | $1,093,781 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI109842 | NFAT, bZIP proteins, and transcriptional programs in lymphocytes | 000 | 35 | NIH | 2/15/2023 | $842,353 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI118626 | Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment | 002 | 9 | NIH | 6/1/2023 | $2,391,540 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI101423 | The role of TRAIL in immune control of cytomegalovirus | 000 | 10 | NIH | 5/4/2023 | $549,000 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI040127 | Signal transduction and gene induction in lymphocytes | 000 | 31 | NIH | 8/3/2023 | $658,800 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI153500 | Maternal Antibody-Mediated Enhancement of Dengue Pathogenesis | 000 | 3 | NIH | 1/27/2023 | $568,385 |
|
